• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Are ACE Inhibitors and ARBs Associated with Increased COVID-19 Susceptibility?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Hippisley-Cox et al. (Heart, 2020) used a large population study to investigate whether there is an association between ACE inhibitors and ARBs and COVID-19 disease susceptibility and progression

METHODS:

  • Prospective cohort study
  • Setting
    • General practices in England
  • Participants
    • Adults aged 20 to 99 years
  • Exposures
    • ACE inhibitors and ARB drugs
  • Study design
    • Cox proportional hazards models were used to derive adjusted hazard ratio
    • Results adjusted for confounders such as sociodemographic factors, concurrent medications and geographical region
  • Primary outcome
    • RT-PCR confirmed COVID-19
    • COVID-19 that resulted in ICU care

RESULTS:

  • 19,486 patients had COVID-19
    • Received ICU care: 1286
  • ACE inhibitors and ARBs were associated with a significantly reduced risk of COVID-19
    • ACE inhibitors
      • Adjusted HR 0.71 (95% CI, 0.67 to 0.74)
    • ARBs
      • Adjusted HR 0.63 (95% CI, 0.59 to 0.67)
  • Neither ACE inhibitors nor ARBS were associated with an increased risk of ICU care
    • ACE inhibitors
      • Adjusted HR 0.89 (95% CI, 0.75 to 1.06)
    • ARBs
      • Adjusted HR 1.02 (95% CI, 0.83 to 1.25)
  • The risk of COVID-19 disease associated with ACE inhibitors was higher in Caribbean and Black African groups vs white group | The risk of COVID-19 disease associated with ARBs was higher in the Black African group vs the white group

CONCLUSION:

  • ACE inhibitors and ARBs were associated with a reduced risk of COVID-19
  • ACE inhibitors and ARBS was not associated with an increased risk of ICU care
  • The authors state

Variations between different ethnic groups raise the possibility of ethnic-specific effects of ACE inhibitors/ARBs on COVID-19 disease susceptibility and severity which deserves further study

Learn More – Primary Sources:

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people


Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

COVID-19, ACE Inhibitors and ARBs: Professional Guidance and Evidence Update
Cardiac Injury: A Feature of COVID-19
COVID-19 and NSAIDs: Is There Reason for Concern with Use of Ibuprofen?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site